Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesse D Bloom

Showing results (141-150 of 253) with videos related to

Pageof 26
Sort By:
Cell Reports|December 26, 2019
Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of HumansSeth J Zost, Juhye Lee, Megan E Gumina, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Complex structural variation, phylogeny, and disease associations of the mucin pangenomeElizabeth G Plender, Timofey Prodanov, Jiadong Lin, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Coevolutionary constraints of Zika virus nonstructural protein 5 replication and interferon antagonism activitiesR Blake Richardson, Caroline Kikawa, Amit Garg, et al.
Nucleic Acids Research|June 12, 2025
The mutation rate of SARS-CoV-2 is highly variable between sites and is influenced by sequence context, genomic region, and RNA structureHugh K Haddox, Georg Angehrn, Luca Sesta, et al.
Biorxiv : the Preprint Server for Biology|September 12, 2022
Receptor binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2Ariana Ghez Farrell, Bernadeta Dadonaite, Allison J Greaney, et al.
Elife|August 28, 2019
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutininJuhye M Lee, Rachel Eguia, Seth J Zost, et al.
Viruses|September 23, 2022
Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2Ariana Ghez Farrell, Bernadeta Dadonaite, Allison J Greaney, et al.
Elife|February 23, 2026
High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strainsCaroline Kikawa, Andrea N Loes, John Huddleston, et al.
Biorxiv : the Preprint Server for Biology|February 4, 2022
Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktailAmin Addetia, Young-Jun Park, Tyler Starr, et al.
Nature|July 3, 2024
Spike deep mutational scanning helps predict success of SARS-CoV-2 cladesBernadeta Dadonaite, Jack Brown, Teagan E McMahon, et al.
Pageof 26

Showing results (141-150 of 253) with videos related to

Sort By:
Pageof 26
Cell Reports|December 26, 2019
Identification of Antibodies Targeting the H3N2 Hemagglutinin Receptor Binding Site following Vaccination of HumansSeth J Zost, Juhye Lee, Megan E Gumina, et al.
Medrxiv : the Preprint Server for Health Sciences|July 10, 2026
Complex structural variation, phylogeny, and disease associations of the mucin pangenomeElizabeth G Plender, Timofey Prodanov, Jiadong Lin, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Coevolutionary constraints of Zika virus nonstructural protein 5 replication and interferon antagonism activitiesR Blake Richardson, Caroline Kikawa, Amit Garg, et al.
Nucleic Acids Research|June 12, 2025
The mutation rate of SARS-CoV-2 is highly variable between sites and is influenced by sequence context, genomic region, and RNA structureHugh K Haddox, Georg Angehrn, Luca Sesta, et al.
Biorxiv : the Preprint Server for Biology|September 12, 2022
Receptor binding domain (RBD) antibodies contribute more to SARS-CoV-2 neutralization when target cells express high levels of ACE2Ariana Ghez Farrell, Bernadeta Dadonaite, Allison J Greaney, et al.
Elife|August 28, 2019
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutininJuhye M Lee, Rachel Eguia, Seth J Zost, et al.
Viruses|September 23, 2022
Receptor-Binding Domain (RBD) Antibodies Contribute More to SARS-CoV-2 Neutralization When Target Cells Express High Levels of ACE2Ariana Ghez Farrell, Bernadeta Dadonaite, Allison J Greaney, et al.
Elife|February 23, 2026
High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strainsCaroline Kikawa, Andrea N Loes, John Huddleston, et al.
Biorxiv : the Preprint Server for Biology|February 4, 2022
Structural changes in the SARS-CoV-2 spike E406W mutant escaping a clinical monoclonal antibody cocktailAmin Addetia, Young-Jun Park, Tyler Starr, et al.
Nature|July 3, 2024
Spike deep mutational scanning helps predict success of SARS-CoV-2 cladesBernadeta Dadonaite, Jack Brown, Teagan E McMahon, et al.
Pageof 26